Issue 8, 2019

Synthesis of bicyclic 1,4-thiazepines as novel anti-Trypanosoma brucei brucei agents

Abstract

1,4-Thiazepines derivatives are pharmacologically important heterocycles with different applications in medicinal chemistry. In the present work, we describe the preparation of new bicyclic thiazolidinyl-1,4-thiazepines 3 by reaction between azadithiane compounds and Michael acceptors. The reaction scope was explored and the yields were optimized. The activity of the new compounds was evaluated against Nippostrongylus brasiliensis and Caenorhabditis elegans as anthelmintic models and Trypanosoma brucei brucei. The most active compound was 3l, showing an EC50 = 2.8 ± 0.7 μM against T. b. brucei and a selectivity index >71.

Graphical abstract: Synthesis of bicyclic 1,4-thiazepines as novel anti-Trypanosoma brucei brucei agents

Supplementary files

Article information

Article type
Research Article
Submitted
01 Feb 2019
Accepted
09 Jun 2019
First published
11 Jun 2019

Med. Chem. Commun., 2019,10, 1481-1487

Synthesis of bicyclic 1,4-thiazepines as novel anti-Trypanosoma brucei brucei agents

F. Vairoletti, A. Medeiros, P. Fontán, J. Meléndrez, C. Tabárez, G. Salinas, J. Franco, M. A. Comini, J. Saldaña, V. Jancik, G. Mahler and C. Saiz, Med. Chem. Commun., 2019, 10, 1481 DOI: 10.1039/C9MD00064J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements